Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 1/2014

01-02-2014 | Editorial

Acta Diabetologica is 50 and well: long live Acta!

Author: Massimo Porta

Published in: Acta Diabetologica | Issue 1/2014

Login to get access

Excerpt

Acta Diabetologica has gone through a number of important changes this past year. First, and for the better, its Impact Factor enjoyed an impressive rise. Second, more worryingly, its authoritative and well-experienced Editors-in-Chief stepped down after achieving this rewarding result. Fortunately, Professors Guido Pozza and Renato Lauro, to whom heartfelt thanks are due for their steady guidance of the journal, will continue to make their experience available as Founding Editor and Honorary Editor, respectively. Thirdly, having been established in 1964 as Acta Diabetologica Latina, the journal celebrates its 50th birthday and is the oldest active diabetes journal in Europe. …
Literature
1.
Popper KR (2004) Conjectures and refutations: the growth of scientific knowledge (reprinted edn). Routledge, London, ISBN: 0-415-28594-1
2.
Tomasi di Lampedusa G (1958) Il Gattopardo. Feltrinelli, Milan
3.
Begley CG, Ellis LM (2012) Drug development: raise standards for preclinical cancer research. Nature 483:531–533PubMedCrossRef
4.
Prinz F, Schlange T, Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712–713PubMedCrossRef
5.
Fanelli D (2012) Negative results are disappearing from most disciplines and countries. Scientometrics 90:891–904CrossRef
6.
Godlee F, Gale CR, Martyn CN (1998) Effect on the quality of peer review of blinding reviewers and asking them to sign their reports. A randomized controlled trial. JAMA 280:237–240PubMedCrossRef
7.
Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 343:d4169PubMedCentralPubMedCrossRef
8.
Kuhn TS (1962) The structure of scientific revolutions. The University of Chicago Press, Chicago
9.
Mering JV, Minkowsky O (1899) Diabetes mellitus nach Pankreasextirpation. Centralblatt fur Klinische Medizin 23:393
10.
Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (1922) Pancreatic extracts in the treatment of X diabetes mellitus: preliminary report. Can Med Assoc J 12:141–146PubMedCentralPubMed
11.
Loubatières A (1944) Analyse du mécanisme de l’action hypoglycémiante du p-amino-benzène-sulfamido-alkilthiodiazols. C R Soc Biol (Paris) 183:830
12.
13.
Rahbar S, Blumenfeld O, Ranney HM (1969) Studies of an unusual haemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 36:838–843PubMedCrossRef
14.
15.
Metadata
Title
Acta Diabetologica is 50 and well: long live Acta!
Author
Massimo Porta
Publication date
01-02-2014
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2014
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0554-6

Other articles of this Issue 1/2014

Acta Diabetologica 1/2014 Go to the issue

Case Report

Deterioration of glycemic control after corticosteroid administration in islet autotransplant recipients: a cautionary tale

Letter to the Editor

Geographic variation in the frequency of abdominal adiposity and metabolic syndrome in Italian adolescents with type 1 diabetes

Original Article

Resting heart rate predicts metabolic syndrome in apparently healthy non-obese Japanese men

Original Article

In vitro effects of resveratrol on oxidative stress in diabetic platelets

Original Article

St. John’s wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity

Thanks to Reviewers

Thanks to Reviewers 2013
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits